首页> 美国卫生研究院文献>BMC Cancer >Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

【2h】

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

机译：临床病理参数对新辅助多西他赛和阿霉素化疗治疗的II / III期乳腺癌的预后影响：三阴性乳腺癌的悖论特征

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundPrognostic factors in locally advanced breast cancer treated with neoadjuvant chemotherapy differ from those of early breast cancer. The purpose of this study was to identify the clinical significance of potential predictive and prognostic factors in breast cancer patients treated by neoadjuvant chemotherapy.

机译：背景新辅助化疗治疗的局部晚期乳腺癌的预后因素与早期乳腺癌不同。这项研究的目的是确定通过新辅助化疗治疗的乳腺癌患者中潜在的预测和预后因素的临床意义。

著录项

期刊名称 BMC Cancer
作者
Bhumsuk Keam; Seock-Ah Im; Hee-Jun Kim; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; Dong-Wan Kim; Woo Kyung Moon; Tae-You Kim; In Ae Park; Dong-Young Noh; Dae Seog Heo; Sung Whan Ha; Yung-Jue Bang;
展开▼
作者单位

展开▼
年(卷),期 2007(7),-1
年度 2007
页码 203
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of Neoadjuvant Chemotherapy in Stage II-III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates Surgical Results From CALGB 40603 (Alliance) [J] . Golshan Mehra, Cirrincione Constance T., Sikov William M., Annals of Surgery . 2015,第3期

机译：II-III期三阴性乳腺癌新辅助化疗对保乳手术资格和保乳率的影响CALGB 40603（联盟）的手术结果
2. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance) [J] . Sikov William M., Berry Donald A., Perou Charles M., Journal of Clinical Oncology . 2015,第1期

机译：在每周一次的紫杉醇新辅助治疗中加用卡铂和/或贝伐单抗后加剂量密集的阿霉素和环磷酰胺对II至III期三阴性乳腺癌病理完全缓解率的影响：CALGB 40603（联盟）
3. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance) [J] . Sikov William M., Berry Donald A., Perou Charles M., Journal of Clinical Oncology . 2015,第1期

机译：在每周一次的紫杉醇新辅助治疗中加用卡铂和/或贝伐单抗后加剂量密集的阿霉素和环磷酰胺对II至III期三阴性乳腺癌病理完全缓解率的影响：CALGB 40603（联盟）
4. Correlation based Feature Selection impact on the classification of breast cancer patients response to neoadjuvant chemotherapy [C] . S. Rosati, C. M. Gianfreda, G. Balestra, International Symposium on Medical Measurements and Applications . 2018

机译：基于相关特征选择对乳腺癌患者新辅助化疗反应分类的影响
5. Prognostic significance of some clinical, histopathological and biological parameters for survival of node-negative breast cancer patients treated in University Medical centre Maribor in the period 2000-2009 [D] . Fokter Dovnik, Nina. 2017

机译：2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床，组织病理学和生物学参数的预后意义
6. Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates [O] . Mehra Golshan, Constance T. Cirrincione, William M. Sikov, -1

机译：II-III期三阴性乳腺癌新辅助化疗对保乳手术资格和保乳率的影响
7. Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer [O] . Kim Dong-Wan, Han Wonshik, Chie Eui, 2007

机译：临床病理参数对新辅助多西紫杉醇和阿霉素化疗治疗的II / III期乳腺癌的预后影响：三阴性乳腺癌的悖论特征

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅